Specialty and Primary care
Our commitment to health and integrated therapies
At Angelini Pharma, we are dedicated to improving the health and quality of life of people through scientifically grounded and patient-centered solutions. We believe in the power of integrated therapy, an approach that considers the complexity of each patient’s needs and the multifaceted nature of disease offering complementary solutions. Our portfolio is designed comprehensively to meet the challenges of pain management, fever treatment, and infectious diseases. Through experience, research, and continuous commitment, our products are united by a common goal: to provide effective, evidence-based solutions that support both acute and chronic conditions, improving outcomes and easing the journey to recovery.
Pain management: targeted therapies for meaningful relief
Effective pain management is a fundamental pillar of medicine, essential not only for alleviating suffering but also for supporting recovery and enhancing patients’ overall well-being. We are committed to provide a comprehensive portfolio of prescription medications, effectively covering all stages of the analgesic ladder. Every therapeutic solution is specifically tailored to address individual patient needs, ensuring effective relief and improved quality of life.
Fever management: clinical expertise and ongoing education for optimal care
Fever is one of the body’s most frequent responses to infection or inflammation, often causing significant discomfort, particularly in children. Effective fever management is essential to preserving the health and well-being of both adult and pediatric patients. At Angelini Pharma, we bring decades of expertise in the treatment of fever and cold-related symptoms, with a strong focus on pediatric care. Our goal is to support a more holistic understanding of fever—not just as a symptom to suppress, but as part of a broader clinical picture that requires thoughtful and individualized care.
Anti-Infectives: promoting responsible use to combat antibiotic resistance
Antibiotic resistance represents one of the most urgent global health threats, compromising the efficacy of treatments and challenging healthcare systems worldwide. Advancing innovation in the antibiotic landscape not only enhances therapeutic outcomes but also facilitates earlier hospital discharge—helping to reduce system strain while significantly improving patient quality of life.
At Angelini Pharma, we are firmly committed to addressing this challenge through a comprehensive approach that includes antimicrobial stewardship, the promotion of responsible prescribing practices, and raising awareness through continuous medical educational initiatives.
Angelini Pharma's commitment to excellence in Specialty and Primary Care is expressed through an integrated, diversified and comprehensive portfolio of therapeutic solutions. Through continuous innovation, targeted medical education, and awareness initiatives, our company reaffirms its dedication to advancing healthcare excellence, always with patient care and well-being at core of our mission.
